Orphan drug status approval for Acanthamoeba Keratitis received by Profounda for Miltefosine

Orphan indication received by Profounda is for the treatment of Acanthamoeba Keratitis, also commonly known as AK usually associated with contact lens wear.


Featured Posts
Recent Posts
No tags yet.
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

© Profounda Pharmaceuticals